AMCP Nexus 2026

Attendees, exhibitors & solutions

Who this event is for

Industry trends

Key trends shaping this market and its wider industry.

Arrival airports

Choose from the following airports, with convenient access to the event and venue.

Hotel tiers

A range of accommodation options near the venue and across key areas.

Local transport

Get around the city with these convenient transport options.

Frequently asked

Glossary

1

Managed care pharmacy

A pharmacy practice area focused on optimizing medication use, cost and outcomes within health plans, PBMs and other risk-bearing payer organizations.

2

Formulary

The list of medicines a health plan or PBM prefers or covers, often tiered by cost sharing and clinical criteria.

3

Pharmacy benefit manager (PBM)

An organization that administers pharmacy benefits for health plans and employers, including claims processing, network management and formulary operations.

4

Prior authorization

A utilization management process in which a prescriber must obtain payer approval before a medicine or service is covered.

5

Step therapy

A utilization management rule requiring patients to try one or more preferred therapies before a more expensive or specialized therapy is covered.

6

HEOR

Health economics and outcomes research, used to assess the clinical, economic and humanistic value of medicines and pharmacy services.

7

AMCP Format for Formulary Submissions

A standardized AMCP template that manufacturers use to submit clinical and economic evidence to payers for formulary review.

8

Value-based contracting

An agreement in which payment or rebates are tied to real-world outcomes, adherence or other performance measures rather than volume alone.

9

Specialty pharmacy

A pharmacy model for high-cost, complex or limited-distribution medicines that includes clinical support, adherence monitoring and patient education.

10

Medication therapy management (MTM)

A pharmacist-led service that reviews a patient's medications to improve adherence, reduce duplication and manage interactions or side effects.

11

Real-world evidence (RWE)

Evidence derived from routine clinical practice, claims, registries or patient-reported data rather than controlled trials alone.

12

Medical benefit versus pharmacy benefit

The coverage pathway for a drug. Medical benefit drugs are typically administered in clinics or hospitals, while pharmacy benefit drugs are dispensed through pharmacies and managed by a PBM.

13

Rebate

A payment or discount negotiated between a manufacturer and a payer or PBM, often linked to formulary placement or utilization.

14

Utilization management

Payer tools such as prior authorization, quantity limits and step therapy that guide appropriate and cost-effective use of medicines and services.

15

Biosimilar

A biologic product highly similar to an approved reference biologic, with no clinically meaningful differences in safety, purity and potency.